http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103333168-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee33b0e3e7398cf6fc957eeee59d510
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9bea9143c1f32dfed3bb8645e9a15c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b9b001155f71fc0eb769a5aa0080be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ac8f7c53415652a63324997d3dbb8ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_568162b73cb25642773d76787279bd69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed5ac2d47d6fc9aab293b432acfdd0b8
publicationDate 2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103333168-A
titleOfInvention A kind of amide compound and its preparation method and application
abstract The invention discloses an amide compound, a preparation method and application thereof. The structural formula of amide compounds is shown in formula I or formula II, in which, R1 and R2 both represent H, methyl, trifluoromethyl or halogen, and R1 and R2 are the same or different; R3 represents H , hydroxymethyl, aminomethyl or C 1-2 alkyl carboxylate; R 4 represents H, methyl or isopropyl; X represents CH, N or O, and n is an integer between 0 and 3. The present invention also provides pharmaceutically acceptable salts of the amide compounds represented by formula I or formula II. The preparation method provided by the present invention starts from simple and easy-to-obtain raw materials, and obtains imidazol[1,2-a][1,8]-naphthyridine amide compounds through 4 to 5 steps of reaction; the amide compounds provided by the present invention It has good activity of inhibiting HCV virus.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11345666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108794485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107827841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108059638-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108059638-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113416197-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113416197-B
priorityDate 2013-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013059559-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467976343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468306778

Total number of triples: 28.